Blue Jay Capital Management’s Edwards Lifesciences EW Stock Holding History

Blue Jay Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$7.95M	Sell	201,798 -68,202	-25%	-$2.49M	5.42%	8
2017 Q1	$8.47M	Sell	270,000 -39,087	-13%	-$1.22M	4.16%	18
2016 Q4	$9.65M	Buy	+309,087	New	+$10M	5.83%	14
2016 Q1	–	Sell	-757,500	Closed	-$19.9M	–	20
2015 Q4	$19.9M	Sell	757,500 -146,604	-16%	-$3.81M	6.72%	2
2015 Q3	$21.4M	Buy	904,104 +413,136	+84%	+$9.97M	8.41%	1
2015 Q2	$11.7M	Sell	490,968 -109,032	-18%	-$2.46M	3.14%	18
2015 Q1	$14.2M	Buy	600,000 +240,000	+67%	+$5.38M	5%	9
2014 Q4	$7.64M	Buy	+360,000	New	+$7.23M	3.41%	20

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Blue Jay Capital Management's EW Position: Q2 2017 in Review

Blue Jay Capital Management reduced its Edwards Lifesciences (EW) stake by 25% in Q2 2017, selling an estimated $2.49M and leaving 201,798 shares worth $7.95M. The position accounts for 5.42% of the portfolio, ranked #8.

Blue Jay Capital Management first reported a position in EW in Q4 2014 and has held it in 8 quarters since. The position peaked at $21.4M in Q3 2015. 721 funds tracked by Wall St. Rank hold EW as of Q2 2017.

Blue Jay Capital Management held 201,798 shares of Edwards Lifesciences worth $7.95M as of Q2 2017.
Blue Jay Capital Management sold 68,202 Edwards Lifesciences shares in Q2 2017, an estimated $2.49M.
Edwards Lifesciences made up 5.42% of Blue Jay Capital Management's portfolio in Q2 2017, its #8 holding.
Blue Jay Capital Management first reported a position in Edwards Lifesciences in Q4 2014 and has held it in 8 quarters since.
Blue Jay Capital Management's Edwards Lifesciences position peaked at $21.4M in Q3 2015.
721 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2017.

Based on Blue Jay Capital Management's 13F filing for Q2 2017, filed 11 Aug 2017.